
    
      Randomized double-blind clinical trial. Study carried out in a single center between January
      and April 2017. 60 eyes were included that were randomly divided in a 1: 1 ratio into two
      groups. The first group received placebo (hydroxypropylmethylcellulose drops) while the
      second group received 0.6% besifloxacin drops four times a day for 3 days. All of them had a
      conjunctival cul-de-sac culture before and after treatment.
    
  